GlassScriptPhysician profile
John C Foster
NPI 1376563429
$4,216.11
in general payments reported to CMS, 2019-2025
38 companies · $40.05 in 2025
The $40.05 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $627 · 2020: $339 · 2021: $453 · 2022: $838 · 2023: $1,267 · 2024: $653 · 2025: $40.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,933 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,933.45 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $461.34 | 2023-2024 | Gemtesa, Myfembree |
| Pfizer INC. | $401.29 | 2019-2024 | |
| Abbvie INC. | $387.01 | 2019-2023 | |
| Myriad Women'S Health, INC. | $322.66 | 2023 | Myrisk |
| Amgen INC. | $308.26 | 2019-2024 | Prolia, Evenity |
| Astellas Pharma US INC | $260.69 | 2019-2024 | Veozah, Myrbetriq |
| Medtronic, INC. | $197.62 | 2022-2024 | Ligasure |
| Urovant Sciences INC | $185.08 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $164.24 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $139.11 | 2019-2024 | |
| Therapeuticsmd, INC. | $108.56 | 2019-2022 | |
| Hologic Sales and Service, LLC | $106.02 | 2019-2025 | Aptima |
| Millicent US INC | $95.88 | 2023-2024 | Intrarosa, Femring |
| Avion Pharmaceuticals | $89.73 | 2023 | Balcoltra |
| Aspira Women'S Health INC | $82.82 | 2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.